This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Clinical Lab Tests Measure Heart Disease Risk; Guide Prevention And Treatment

Predicting Risk of Coronary Disease

Lab tests also can help predict a patient's risk of having a heart attack. A blood test for high sensitivity C-reactive protein (CRP) detects the presence of inflammation that can lead to blockage of arteries. The CRP test, combined with tests for cholesterol and triglycerides, helps doctors evaluate the presence of heart disease. The CRP test costs between $60 and $150, but can be critical in helping avoid heart attack that can cost $28,000.

In one Harvard Women's Health study, CRP was a better predictor of heart attack risk than even cholesterol levels. Women in the study group with the highest CRP levels were four times as likely to have died from coronary disease or to have suffered a nonfatal heart attack or stroke.

People who have high CRP levels are often treated with cholesterol-lowering drugs called statins. One study showed that use of a statin drug in people with high CRP levels --- even though they did not have high levels of the "bad" LDL cholesterol --- led to significant decreases in major cardiovascular events such as heart attacks or stroke.

"Clinical lab tests like the CRP test can identify patients at risk so physicians and patients can take the steps necessary to reduce it," said Mertz.

The American Clinical Laboratory Association is a non-profit group representing the nation's clinical  laboratories. See www.acla.com .  Results for Life, the group's educational campaign, focuses on the value of laboratory medicine. See www.labresultsforlife.org.

Contact: Scott McGoohan, 202-637-9466

SOURCE American Clinical Laboratory Association

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs